Gene Ontology Definition Changes
Files used:
- file 1 (old): 02:09:2011 15:07, cvs revision 1.2232
- file 2 (new): 09:09:2011 11:25, cvs revision 1.2244
- Database: unknown DB type, unknown DB release name
Terms with changed definitions
GO:0007219 : Notch signaling pathway
OLD: The series of molecular signals initiated by binding of an extracellular ligand to a Notch receptor on the surface of the target cell.
NEW: The series of molecular signals initiated by binding of the receptor Notch to an extracellular ligand.
GO:0008101 : decapentaplegic signaling pathway
(was decapentaplegic receptor signaling pathway)
OLD: The series of molecular signals generated as a consequence of a decapentaplegic receptor binding to one of its physiological ligands.
NEW: The series of molecular signals generated as a consequence of the signal decapentaplegic binding to one of its physiological receptors.
GO:0008293 : torso signaling pathway
OLD: The series of molecular signals generated as a consequence of the torso transmembrane receptor tyrosine kinase binding to its physiological ligand.
NEW: The series of molecular signals generated as a consequence of the transmembrane receptor tyrosine kinase torso binding to its physiological ligand.
GO:0019221 : cytokine-mediated signaling pathway
OLD: Any series of molecular signals generated as a consequence of a cytokine or chemokine binding to a cell surface receptor.
NEW: Any series of molecular signals generated as a consequence of a cytokine binding to a cell surface receptor.
GO:0023035 : CD40 signaling pathway
OLD: Any series of molecular signals generated as a consequence of binding to the receptor CD40.
NEW: Any series of molecular signals generated as a consequence of the receptor CD40 binding to one of its physiological ligands.
GO:0038027 : apolipoprotein A-I-mediated signaling pathway
OLD: Any series of molecular signals initiated by the binding of a cell surface receptor to apolipoprotein A-I.
NEW: Any series of molecular signals initiated by the binding of apolipoprotein A-I to a cell surface receptor.
GO:0043281 : regulation of cysteine-type endopeptidase activity involved in apoptotic process
(was regulation of caspase activity)
OLD: Any process that modulates the activity of a caspase, any of a group of cysteine proteases involved in apoptosis.
NEW: Any process that modulates the activity of a cysteine-type endopeptidase involved in apoptosis.
GO:0045500 : sevenless signaling pathway
OLD: The series of molecular signals generated as a consequence of the sevenless receptor binding to one of its physiological ligands.
NEW: The series of molecular signals generated as a consequence of the receptor sevenless binding to one of its physiological ligands.
GO:0070120 : ciliary neurotrophic factor-mediated signaling pathway
OLD: A series of molecular signals generated as a consequence of ciliary neurotrophic factor binding to a cell surface receptor.
NEW: A series of molecular signals generated as a consequence of a ciliary neurotrophic factor binding to a cell surface receptor.
GO:0090097 : regulation of decapentaplegic signaling pathway
(was regulation of decapentaplegic receptor signaling pathway)
OLD: Any process that modulates the frequency, rate, or extent of the decapentaplegic receptor signaling pathway. The decapentaplegic receptor signaling pathway is the series of molecular signals generated as a consequence of a decapentaplegic receptor binding to one of its physiological ligands.
NEW: Any process that modulates the frequency, rate, or extent of the decapentaplegic signaling pathway. The decapentaplegic signaling pathway is the series of molecular signals generated as a consequence of the signal decapentaplegic binding to one of its physiological receptors.
GO:0090098 : positive regulation of decapentaplegic signaling pathway
(was positive regulation of decapentaplegic receptor signaling pathway)
OLD: Any process that increases the frequency, rate, or extent of the decapentaplegic receptor signaling pathway. The decapentaplegic receptor signaling pathway is the series of molecular signals generated as a consequence of a decapentaplegic receptor binding to one of its physiological ligands.
NEW: Any process that increases the frequency, rate, or extent of the decapentaplegic signaling pathway. The decapentaplegic signaling pathway is the series of molecular signals generated as a consequence of the signal decapentaplegic binding to one of its physiological receptors.
GO:0090099 : negative regulation of decapentaplegic signaling pathway
(was negative regulation of decapentaplegic receptor signaling pathway)
OLD: Any process that decreases the frequency, rate, or extent of the decapentaplegic receptor signaling pathway. The decapentaplegic receptor signaling pathway is the series of molecular signals generated as a consequence of a decapentaplegic receptor binding to one of its physiological ligands.
NEW: Any process that decreases the frequency, rate, or extent of the decapentaplegic signaling pathway. The decapentaplegic signaling pathway is the series of molecular signals generated as a consequence of the signal decapentaplegic binding to one of its physiological receptors.
0 annotations
GO:2000531 : regulation of fatty acid biosynthetic process by regulation of transcription from RNA polymerase II promoter
(was regulation of transcription from RNA polymerase II promoter involved in fatty acid biosynthetic process)
OLD: Any regulation of transcription from RNA polymerase II promoter that is involved in fatty acid biosynthetic process.
NEW: Any process that modulates the frequency, rate or extent of the biosynthesis of fatty acids, by modulating the frequency, rate or extent of transcription from an RNA polymerase II promoter.